Publicaciones científicas
Revisiting intracavitary immunotherapy of cancer
13-may-2022
| Revista: Clinical Cancer Research
Fernando Aranda 1 , Iñaki Eguren-Santamaria 2 , Angela Bella 1 , Pedro Berraondo 1 , Ignacio Melero 3
Abstract
Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects.
CITA DEL ARTÍCULO Clin Cancer Res. 2022 May 13;28(10):1993-1995.
doi: 10.1158/1078-0432.CCR-22-0201.
Nuestros autores
Codirector
Servicio de Inmunología e Inmunoterapia
Sede Pamplona
Especialista
Departamento de Oncología Médica
Sede Pamplona